NCT03542162View on ClinicalTrials.gov

Healaflow Patch for the Treatment of Rhegmatogenous Retinal Detachment

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

December 1, 2018

Conditions
Rhegmatogenous Retinal Detachment
Interventions
BIOLOGICAL

Healaflow

For the RRD patients, after 27G PPV, air-liquid exchange and endolaser photocoagulation around the tear(s), Healaflow is going to be fully covered on the surface of all retinal tears using 27G needle, the amount of Healaflow injection was determined according to the size of tears.

All Listed Sponsors
lead

Tianjin Medical University Eye Hospital

OTHER

NCT03542162 - Healaflow Patch for the Treatment of Rhegmatogenous Retinal Detachment | Biotech Hunter | Biotech Hunter